Literature DB >> 25515126

[Importance of cellular tight junction complexes in the development of periprosthetic leakage after prosthetic voice rehabilitation].

K J Lorenz1, K Kraft, F Graf, C Pröpper, K Steinestel.   

Abstract

BACKGROUND: The use of voice prostheses is currently the gold standard in voice rehabilitation after total laryngectomy. This method combines low complication rates and excellent rehabilitation results; however, approximately 30% of patients show periprosthetic leakage or severe fistula enlargement after laryngectomy and prosthetic voice restoration within the first 4 years. The development of this enlargement is controversially discussed in the literature but recently published studies have shown that high esophageal reflux plays a key role in this process, which leads to an inflammatory reaction and disturbs the intercellular tight junctions in the sense of an epithelial mesenchymal transition (EMT).
MATERIAL AND METHODS: A total of 44 patients underwent 24 h pH monitoring, a sample biopsy from the region of the fistula and a subsequent biomolecular examination for intracellular junction proteins as well as a correlation between the severity of reflux and tracheoesophageal fistula problems before and after antireflux therapy with proton pump inhibitors (PPI).
RESULTS: Immunohistochemical staining revealed decreases in membrane E-cadherin and β-catenin and a significant increase in the cytoplasmic fraction, depending on the severity of inflammation in the fistula tissue. In patients with an improvement of clinical fistula problems under oral PPI treatment an increase of membrane E-cadherin could be shown, whereas patients with persisting fistula enlargement demonstrated a further decrease of E-cadherin.
CONCLUSION: The data indicate a central role of EMT in the development of fistula enlargement after total laryngectomy. Patients with periprosthetic leakage showed a loss of membrane bound E-cadherin and β-catenin with an up-regulation of vimentin expression. In patients with mild or no leakage problems EMT could be resolved by aggressive antireflux treatment, whereas patients without any effect of PPI treatment on the fistula showed no reversal of EMT. These data contribute to the understanding of treatment resistant fistula enlargement after total laryngectomy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25515126     DOI: 10.1007/s00106-014-2951-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  48 in total

1.  [A survey of reflux-associated illnesses in the head and neck area].

Authors:  P Jecker
Journal:  HNO       Date:  2012-03       Impact factor: 1.284

Review 2.  Biomarkers and laryngopharyngeal reflux.

Authors:  J M Wood; D J Hussey; C M Woods; D I Watson; A S Carney
Journal:  J Laryngol Otol       Date:  2011-09-14       Impact factor: 1.469

3.  Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease.

Authors:  Biljana Jovov; Jianwen Que; Nelia A Tobey; Zorka Djukic; Brigid L M Hogan; Roy C Orlando
Journal:  Am J Gastroenterol       Date:  2011-03-29       Impact factor: 10.864

4.  Surgical management of gastroesophageal reflux and outcome after laryngectomy in patients using tracheoesophageal speech.

Authors:  Blair A Jobe; Eben Rosenthal; Tracy T Wiesberg; James I Cohen; John S Domreis; Clifford W Deveney; Brett Sheppard
Journal:  Am J Surg       Date:  2002-05       Impact factor: 2.565

5.  Gastroesophageal reflux disease and postlaryngectomy tracheoesophageal fistula.

Authors:  Salvatore Cocuzza; Marco Bonfiglio; Rita Chiaramonte; Giuseppe Aprile; Antonio Mistretta; Giuseppe Grosso; Agostino Serra
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05       Impact factor: 2.503

6.  Analysis of pepsin in tracheoesophageal puncture sites.

Authors:  Jonathan M Bock; Mary K Brawley; Nikki Johnston; Tina Samuels; Becky L Massey; Bruce H Campbell; Robert J Toohill; Joel H Blumin
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-12       Impact factor: 1.547

7.  The management of periprosthetic leakage in the presence of supra-oesophageal reflux after prosthetic voice rehabilitation.

Authors:  Kai J Lorenz; L Grieser; T Ehrhart; H Maier
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-12-09       Impact factor: 2.503

8.  [Prosthetic voice rehabilitation after laryngectomy. Failures and complications after previous radiation therapy].

Authors:  P Kummer; M Chahoud; M Schuster; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2006-04       Impact factor: 1.284

Review 9.  [Surgical treatment of enlarged trachoesophageal puncture with and without supraesophageal reflux : case report and review of literature].

Authors:  K J Lorenz; H Maier
Journal:  HNO       Date:  2009-12       Impact factor: 1.284

10.  [Coincidence of fistula enlargement and supra-oesophageal reflux in patients after laryngectomy and prosthetic voice restoration].

Authors:  K J Lorenz; T Ehrhart; L Grieser; H Maier
Journal:  HNO       Date:  2009-12       Impact factor: 1.284

View more
  4 in total

1.  [Solving problems after rehabilitation with voice prostheses : Two rare cases of fistula-related complications].

Authors:  K J Lorenz; S Nolte
Journal:  HNO       Date:  2016-07       Impact factor: 1.284

2.  Analysis of Factors Affecting the Longevity of Voice Prosthesis Following Total Laryngectomy with a Review of Literature.

Authors:  Arvind Krishnamurthy; Suhaildeen Khwajamohiuddin
Journal:  Indian J Surg Oncol       Date:  2017-09-06

3.  Influence of proton pump inhibitor therapy on occurrence of voice prosthesis complications.

Authors:  Ana Danic Hadzibegovic; Ana Kozmar; Irzal Hadzibegovic; Drago Prgomet; Davorin Danic
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-17       Impact factor: 2.503

Review 4.  Post-laryngectomy voice rehabilitation with voice prosthesis: 15 years experience of the ENT Clinic of University of Catania. Retrospective data analysis and literature review.

Authors:  A Serra; P Di Mauro; D Spataro; L Maiolino; S Cocuzza
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-12       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.